Stanley Druckenmiller Spring Works Therapeutics, Inc. Transaction History
Duquesne Family Office LLC
- $2.92 Billion
- Q2 2024
A detailed history of Stanley Druckenmiller (Duquesne Family Office LLC) transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Duquesne Family Office LLC holds 1,021,367 shares of SWTX stock, worth $31.3 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
1,021,367Holding current value
$31.3 Million% of portfolio
1.32%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
221Shares Held
67.2MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$200 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$172 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$113 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$110 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$105 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $1.91B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...